Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 175 results for "clinigene"

Eisai & Clinigen to bring breast cancer drug to South Africa
Pharmafile

Clinigen Group plc Change of Joint Broker

13/01/2017 10:00am UK Regulatory (RNS & others) Clinigen (LSE:CLIN) Intraday Stock Chart Today : Friday 13 January 2017 TIDMCLIN RNS Number : 8046T Clinigen Group plc 13 January 2017 13 January 2017 Change of Joint Broker ... ADVFN UK, 5 days ago
CLINIGEN : Change of Joint Broker 4 Traders, 5 days ago
Change of Joint Broker MoneyAM, 5 days ago
[x]  

43 images for clinigene

Proactive Investors USA, 1 week ago
Brief Report.co.uk, 1 month ago
WKRB News, 1 month ago
Pharmafile, 1 month ago
American Banking News, 2 months ago
Shares Magazine, 1 month ago
Octafinance, 2 months ago
Octafinance, 2 months ago
Post Online Media, 2 months ago
AOL UK, 2 months ago
Brief Report.co.uk

Burton pharmaceutical giant Clinigen aims to be big in Japan

A Burton pharmaceutical giant is looking to further extend its reach by opening a new office in Japan. Clinigen, in Centrum 100, is expanding its global pharmaceuticals and services offering with its new venture Clinigen KK in Tokyo. It increases ...
 Brief Report.co.uk1 month ago Clinigen's Halaven Breast Cancer Drug Registered In South Africa  London Stock Exchange1 month ago Clinigen secures South Africa distribution deal  Insider Media Limited1 month ago CLINIGEN : Halaven Breast Cancer Drug Registered In South Africa  4 Traders1 month ago

CLINIGEN : initiates U.S. Managed Access program for TESARO's niraparib for patients with ovarian cancer

Clinigen Group plc's (AIM: CLIN, 'Clinigen') Idis Managed Access (MA) division has partnered with TESARO Inc. (NASDAQ: TSRO), to launch a Managed Access program (also known as an expanded access program (EAP)) for the investigational PARP 1/2 ...
 4 Traders1 day ago Clinigen initiates program for TESARO's niraparib  MoneyAM1 day ago Clinigen begins US Managed Access program for TESARO's niraparib in ovarian cancer patients  Pharmaceutical Business Review9 hours ago Clinigen Release: Company Initiates U.S. Managed Access Program For Tesaro???s Niraparib For Patients With Ovarian Cancer  BioSpace1 day ago
[x]  

CLINIGEN : Launches Access Programme For US Partner's Cancer Therapy

LONDON (Alliance News) - Clinigen Group PLC said Tuesday it has partnered with New York-listed TESARO Inc to launch an expanded access program for a therapy for women who have undergone chemotherapy. Clinigen said the program is being launched in ...
 4 Traders1 day ago Clinigen Launches Access Programme For US Partner's Cancer Therapy  London Stock Exchange1 day ago

CLINIGEN : Idis Signs Distribution Deal With BioQ Pharma

LONDON (Alliance News) - Pharmaceuticals and healthcare services company Clinigen Group PLC on Thursday said its Idis Global Access unit has signed a supply and distribution deal with BioQ Pharma, an infusible products maker. The agreement will ...
 4 Traders1 month ago Clinigen's Idis Signs Distribution Deal With BioQ Pharma  London Stock Exchange1 month ago

Clinigen division teams up with TESARO

(ShareCast News) - Clinigen Group announced on Tuesday that its Idis Managed Access division has partnered with TESARO to launch a managed access program for the investigational PARP 1/2 inhibitor, niraparib. The AIM-traded company said Niraparib ...
 London South East1 day ago
Proactive Investors USA

Clinigen and partner to launch oncology support drug in US

(Before It's News) Clinigen Group PLC ( LON:CLIN ) and its partner Cumberland Pharmaceuticals Inc (NASDAQ: CPIX) are to market a second product in the US through their strategic alliance. Oncology support drug Totect will launch later this ...
 Before It's News1 week ago Mon Clinigen and partner to launch oncology support drug in US  Proactive Investors USA1 week ago Breaking Clinigen and partner to launch oncology support drug in US  Proactive Investors USA1 week ago

Clinigen enters into second agreement with Cumberland Pharmaceuticals

Bianca Boorer (ShareCast News) - Clinigen Group, an AIM listed global pharmaceutical and services company, and Cumberland Pharmaceuticals, a US specialty pharmaceutical company have entered into their second exclusive agreement to commercialise the ...
 BullBearings1 week ago

Market Movers - Top risers and fallers between 10:00 and 11:00

Overall Market Clinigen Group 714.50 0.00% Bb Healthcare Trust Red Ord 1p 104.12 0.00% Diverse Income Trust (The) 93.50 0.00% Kingswalk Investments 1.14 ...
 MoneyAM3 weeks ago

Clinigen to distribute BioQ's pain relief drug in Europe

Maryam Cockar (ShareCast News) - AIM-listed pharmaceutical Clinigen is to distribute BioQ Pharma's post-surgery pain management drug, Ropivacaine Readyfusor. The company's subsidiary Idis Global Access has agreed to supply and distribute the ...
 BullBearings1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less